Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ResMed Inc (NYSE:RMD)

63.65
Delayed Data
As of Jan 20
 +0.75 / +1.19%
Today’s Change
52.37
Today|||52-Week Range
70.90
+2.58%
Year-to-Date
Medical Product Stocks Q4 Earnings Roster: SYK, ISRG, RMD
Jan 20 / Zacks.com - Paid Partner Content
ResMed and Dr. Oz Form SleepScore Labs for Sleep Disorders
Jan 09 / Zacks.com - Paid Partner Content
ResMed (RMD) Q2 Earnings: Disappointment in the Cards?
Jan 13 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close62.90
Today’s open63.27
Day’s range63.06 - 63.91
Volume614,642
Average volume (3 months)887,901
Market cap$9.0B
Dividend yield2.07%
Data as of 4:02pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)+0.81%
Earnings growth (this year)+4.24%
Earnings growth (next 5 years)+10.61%
Revenue growth (last year)+9.52%
P/E ratio26.0
Price/Sales4.87
Price/Book5.28

Competitors

 Today’s
change
Today’s
% change
VARVarian Medical Syste...+0.44+0.49%
NVRONevro Corp-0.94-1.06%
LIVNLivaNova PLC+0.04+0.09%
SPNCSpectranetics Corp+0.20+0.80%
Data as of 4:02pm ET, 01/20/2017

Financials

Next reporting dateJanuary 24, 2017
EPS forecast (this quarter)$0.69
Annual revenue (last year)$1.8B
Annual profit (last year)$352.4M
Net profit margin19.17%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Director
Mick Farrell
President &
Chief Operating Officer
Rob Douglas
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs